NKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient.

ABSTRACT:

SUBMITTER: Sallman DA 

PROVIDER: S-EPMC6119132 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature